Edwards Lifesciences Corporation

EW Healthcare Medical Devices

Edwards Lifesciences Corporation’s revenue for fiscal 2025 (year ended December 2025) was $6.1 billion, up 11.5% from fiscal 2024.

Revenue
+10.5%
EPS
+6.00%
Free cash flow
−1.84%
Total debt
+0.10%

Quarter to September 2026, against a year earlier

101.61 0.79 +0.78%
Market cap
$58.1B
P/E
56.7×
Fwd P/E
36.5×
Dividend yield
—
F-score
5/9
Altman Z
11.54
Beneish M
−2.48
Dividend safety
n/a

Edwards Lifesciences Corporation (EW) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Edwards Lifesciences Corporation (EW) trades at a EV/Sales of 8.2×. Over the past ten years it has ranged from 5.3× (May 2015) to 15.9× (December 2021); the current reading is higher than 44% of that period. That is above the Medical Devices industry median of 2.7× and above the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 7.7× 1.23%
FY2024 7.6× (15.89%)
FY2023 9.1× (11.95%)
FY2022 10.3× (33.07%)
FY2021 15.4× 19.21%
FY2020 12.9× 16.24%
FY2019 11.1× 28.00%
FY2018 8.7× 28.24%
FY2017 6.8× 0.72%
FY2016 6.7× 2.12%

Quarterly newest first

Period EV/Sales Change
Sep 2026 7.0× (7.19%)
Jun 2026 7.5× 8.21%
Mar 2026 7.0× (9.74%)
Dec 2025 7.7× 6.02%
43 more quarters

Against its own ten years

Low 5.3× High 15.9×
Ten-year median 8.6×
Current reading's percentile 39

EV/Sales against peers

Company EV/Sales
PHG Koninklijke Philips N.V. compare 1.7×
GEHC GE HealthCare Technologies Inc. compare 2.1×
ZBH Zimmer Biomet Holdings, Inc. compare 3.2×
BSX Boston Scientific Corporation compare 3.6×
MDT Medtronic PLC compare 4.1×
STE STERIS plc compare 4.2×
SYK Stryker Corporation compare 5.3×
DXCM DexCom, Inc. compare 6.2×
EW Edwards Lifesciences Corporation 8.2×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on EW